FDA Inspection
Daicel Chiral Technologies (India) Private LimitedDaicel Chiral Technologies (India) Private Limited – FDA Inspection, Feb 14, 2024
Record Details
This FDA Inspection record concerns Daicel Chiral Technologies (India) Private Limited, with an inspection on February 14, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 14, 2024
- Product Type
- Drugs
View Company Profile
ID · f7305a4b-40f6-4c12-b1c2-e76322eaaaec
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1229717
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.194(c)Testing and standardization of standards et. al.
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Daicel Chiral Technologies (India) Private Limited
4| Date | Classification | Office | Project area |
|---|---|---|---|
| November 3, 2023 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 8, 2023 | Not classified | Office of Inspections and Investigations | |
| March 26, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 10, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Daicel Chiral Technologies (India) Private Limited
- FDA Inspection 1237349 - 2023-11-03
- FDA Inspection 1200445 - 2023-02-08
- FDA Inspection 1089898 - 2019-03-26
- FDA Inspection 960646 - 2016-02-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.